Kidney function and multiple hemostatic markers: cross sectional associations in the multi-ethnic study of

Ruth Dubin1, Mary Cushman, Aaron R Folsom

  • 1Department of Medicine, Division Nephrology, University of California San Francisco, 521 Parnassus Avenue, San Francisco, CA 94143-0532, USA. ruth.dubin@ucsf.edu

BMC Nephrology
|January 29, 2011
PubMed

Insights

Reduced kidney function (eGFR < 60) is linked to higher levels of blood clotting markers (hemostasis). This dysregulation may explain the increased cardiovascular risk associated with chronic kidney disease (CKD).

Area of Science:

  • Nephrology and Cardiovascular Research
  • Hemostasis and Thrombosis
  • Epidemiology of Chronic Diseases

Background:

  • Chronic kidney disease (CKD), defined by estimated glomerular filtration rate (eGFR) < 60 ml/min/1.73 m2, is a significant independent risk factor for cardiovascular and overall mortality.
  • A potential link between impaired kidney function and hemostatic system abnormalities was hypothesized.

Purpose of the Study:

  • To investigate the association between reduced kidney function (eGFR) and various hemostatic markers.
  • To explore potential mechanisms linking CKD to increased cardiovascular risk through hemostatic dysregulation.

Main Methods:

  • Cross-sectional analysis of 6751 participants from the Multi-Ethnic Study of Atherosclerosis (MESA) with a wide range of kidney function.
  • Kidney function assessed using cystatin C (eGFRcys) and creatinine (eGFRcr).
  • Measured hemostatic markers included sTM, sTF, D-Dimer, vWF, Factor VIII, PAP, TFPI, PAI-1, and fibrinogen, analyzed via multivariable linear regression.

Main Results:

  • Participants with lower eGFRcys (< 60 ml/min/1.73 m2) exhibited significantly higher adjusted levels of multiple hemostatic markers compared to those with eGFRcys >90.
  • Elevated levels were observed for sTM (86%), sTF (68%), D-Dimer (44%), PAP (22%), Factor VIII (17%), TFPI (15%), vWF (12%), and fibrinogen (6%).
  • Similar trends were noted for individuals with moderate kidney dysfunction (eGFRcys 60-90), with no significant differences when categorized by eGFRcr.

Conclusions:

  • A consistent association exists between lower eGFR and elevated hemostatic marker levels across a broad spectrum of kidney function.
  • Dysregulation of the hemostatic system is a potential contributing mechanism for the heightened cardiovascular risk observed in individuals with reduced kidney function.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
Imaging Studies VII: Vascular Imaging01:19

Imaging Studies VII: Vascular Imaging

DefinitionRenal angiography, also known as renal arteriography, is an imaging technique used to obtain a comprehensive view of blood flow and the vascular structure of blood vessels in the kidneys and surrounding areas.PurposeRenal angiography detects blood vessel abnormalities in the kidneys, such as aneurysms, stenosis, thrombosis, vascular tumors, and renal artery stenosis. It evaluates kidney function and guides interventional treatments like angioplasty or stent placement.Pre-Procedure...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...